Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene

Abstract

We utilized mice with homozygous disruption of angiotensin-converting enzyme (ACE) (−/−), mice with heterozygous deletion of ACE (+/−), and wild-type mice (+/+) to test the hypothesis that genetic variation in ACE modulates tissue and plasma angiotensin (ANG) II concentrations. With the use of ANG I as substrate, kidney, heart, and lung ACE activity was reduced 80% in −/− mice compared with +/+ mice. However, ANG II concentrations and ANG II-to-ANG I ratios in the kidney, heart, and lung did not differ among genotypes. In contrast, plasma ANG II concentrations in −/− mice were P < 0.05) and 1.5-fold in the heart (P < 0.05) of −/− versus +/+ mice but did not differ among genotypes in the lung. ANG II formation from enzymes other than ACE and chymase contributed <2% of total ANG II formation in all genotypes. These data suggest that ACE is essential to ANG II formation in the vascular space, whereas chymase may provide an important mechanism in maintaining steady-state ANG II levels in tissue.